Free Trial

Johnson & Johnson (JNJ) Competitors

Johnson & Johnson logo
$155.90 +0.34 (+0.22%)
Closing price 07/3/2025 03:59 PM Eastern
Extended Trading
$155.75 -0.15 (-0.10%)
As of 07/3/2025 04:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

JNJ vs. ISRG, MRNA, NVAX, ABBV, BRK.B, LLY, MRK, PFE, PG, and XOM

Should you be buying Johnson & Johnson stock or one of its competitors? The main competitors of Johnson & Johnson include Intuitive Surgical (ISRG), Moderna (MRNA), Novavax (NVAX), AbbVie (ABBV), Berkshire Hathaway (BRK.B), Eli Lilly and Company (LLY), Merck & Co., Inc. (MRK), Pfizer (PFE), Procter & Gamble (PG), and Exxon Mobil (XOM).

Johnson & Johnson vs. Its Competitors

Intuitive Surgical (NASDAQ:ISRG) and Johnson & Johnson (NYSE:JNJ) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, dividends, risk, analyst recommendations, profitability, valuation and earnings.

Intuitive Surgical has a net margin of 28.41% compared to Johnson & Johnson's net margin of 24.42%. Johnson & Johnson's return on equity of 33.46% beat Intuitive Surgical's return on equity.

Company Net Margins Return on Equity Return on Assets
Intuitive Surgical28.41% 14.43% 12.81%
Johnson & Johnson 24.42%33.46%13.30%

Intuitive Surgical presently has a consensus price target of $588.95, indicating a potential upside of 8.32%. Johnson & Johnson has a consensus price target of $170.88, indicating a potential upside of 9.61%. Given Johnson & Johnson's higher probable upside, analysts plainly believe Johnson & Johnson is more favorable than Intuitive Surgical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Intuitive Surgical
1 Sell rating(s)
4 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.70
Johnson & Johnson
0 Sell rating(s)
11 Hold rating(s)
7 Buy rating(s)
2 Strong Buy rating(s)
2.55

In the previous week, Johnson & Johnson had 37 more articles in the media than Intuitive Surgical. MarketBeat recorded 88 mentions for Johnson & Johnson and 51 mentions for Intuitive Surgical. Johnson & Johnson's average media sentiment score of 1.52 beat Intuitive Surgical's score of 1.42 indicating that Johnson & Johnson is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Intuitive Surgical
43 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Johnson & Johnson
82 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Very Positive

83.6% of Intuitive Surgical shares are owned by institutional investors. Comparatively, 69.6% of Johnson & Johnson shares are owned by institutional investors. 0.7% of Intuitive Surgical shares are owned by company insiders. Comparatively, 0.2% of Johnson & Johnson shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Intuitive Surgical has a beta of 1.64, suggesting that its stock price is 64% more volatile than the S&P 500. Comparatively, Johnson & Johnson has a beta of 0.41, suggesting that its stock price is 59% less volatile than the S&P 500.

Johnson & Johnson has higher revenue and earnings than Intuitive Surgical. Johnson & Johnson is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Intuitive Surgical$8.35B23.33$2.32B$6.8279.73
Johnson & Johnson$88.82B4.22$14.07B$8.9917.34

Summary

Johnson & Johnson beats Intuitive Surgical on 9 of the 17 factors compared between the two stocks.

Get Johnson & Johnson News Delivered to You Automatically

Sign up to receive the latest news and ratings for JNJ and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding JNJ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

JNJ vs. The Competition

MetricJohnson & JohnsonLarge Cap Pharma IndustryMedical SectorNYSE Exchange
Market Cap$375.37B$251.92B$5.53B$20.72B
Dividend Yield3.33%2.86%5.24%3.72%
P/E Ratio17.3427.6227.5228.09
Price / Sales4.224.99421.0238.30
Price / Cash11.8913.8136.8922.53
Price / Book5.2517.618.044.58
Net Income$14.07B$8.49B$3.18B$986.06M
7 Day Performance2.27%1.04%2.90%2.79%
1 Month Performance1.57%0.73%3.70%5.46%
1 Year Performance6.43%-3.27%36.15%15.06%

Johnson & Johnson Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
JNJ
Johnson & Johnson
4.8503 of 5 stars
$155.90
+0.2%
$170.88
+9.6%
+7.0%$375.37B$88.82B17.34138,100Positive News
ISRG
Intuitive Surgical
4.3412 of 5 stars
$541.23
+1.4%
$588.95
+8.8%
+25.1%$193.99B$8.35B79.3615,638Positive News
MRNA
Moderna
4.3809 of 5 stars
$27.64
+1.8%
$46.61
+68.6%
-73.7%$10.69B$3.24B-3.175,800Options Volume
Gap Up
NVAX
Novavax
4.4902 of 5 stars
$6.36
-0.2%
$17.00
+167.3%
-45.9%$1.03B$682.16M2.401,990
ABBV
AbbVie
4.9067 of 5 stars
$184.23
+1.1%
$211.29
+14.7%
+15.7%$325.42B$56.33B78.4055,000Trending News
Analyst Revision
BRK.B
Berkshire Hathaway
0.4999 of 5 stars
$484.32
-0.3%
$520.00
+7.4%
+19.5%$1.04T$371.43B12.91392,400
LLY
Eli Lilly and Company
4.9879 of 5 stars
$777.66
+0.3%
$1,011.61
+30.1%
-13.2%$737.02B$45.04B63.2847,000Trending News
MRK
Merck & Co., Inc.
4.9962 of 5 stars
$78.94
-0.2%
$109.19
+38.3%
-35.7%$198.22B$63.92B11.4975,000Positive News
PFE
Pfizer
4.9757 of 5 stars
$24.18
0.0%
$29.17
+20.6%
-8.1%$137.47B$63.63B17.5281,000Trending News
PG
Procter & Gamble
4.9149 of 5 stars
$158.62
-0.8%
$178.45
+12.5%
-1.9%$371.89B$84.04B25.18108,000Positive News
XOM
Exxon Mobil
4.956 of 5 stars
$107.83
-1.4%
$125.10
+16.0%
-2.3%$464.71B$339.89B14.3061,000Trending News
Analyst Upgrade

Related Companies and Tools


This page (NYSE:JNJ) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners